Summary: In this episode, NPS MedicineWise CEO Steve Morris speaks with the head of the Therapeutic Goods Administration (TGA) John Skerritt about how the TGA is supporting clinicians and consumers during the COVID-19 pandemic. They discuss some of the unique challenges the TGA has faced and the way it has adapted to these, along with innovations that should be continued beyond the pandemic period. Further reading: The Therapeutic Goods Administration: www.TGA.gov.au The refreshed NPS MedicineWise COVID-19 information hub: www.nps.org.au/coronavirus
